|
|
|
|
LEADER |
02056nam a22004215i 4500 |
001 |
978-4-431-27172-7 |
003 |
DE-He213 |
005 |
20151204190719.0 |
007 |
cr nn 008mamaa |
008 |
100301s2005 ja | s |||| 0|eng d |
020 |
|
|
|a 9784431271727
|9 978-4-431-27172-7
|
024 |
7 |
|
|a 10.1007/b138712
|2 doi
|
040 |
|
|
|d GrThAP
|
050 |
|
4 |
|a RC841-858.P35
|
072 |
|
7 |
|a MJJ
|2 bicssc
|
072 |
|
7 |
|a MED031000
|2 bisacsh
|
082 |
0 |
4 |
|a 616.36
|2 23
|
245 |
1 |
0 |
|a NASH and Nutritional Therapy
|h [electronic resource] /
|c edited by Kiwamu Okita.
|
264 |
|
1 |
|a Tokyo :
|b Springer Tokyo,
|c 2005.
|
300 |
|
|
|a XII, 117 p. 40 illus., 5 illus. in color.
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
347 |
|
|
|a text file
|b PDF
|2 rda
|
505 |
0 |
|
|a Nonalcoholic Fatty Liver (NAFL): Overview -- Role of Leptin in Pathogenesis of NASH -- Zone 3 Predominance of Histopathological Features in Nonalcoholic Steatohepatitis -- Genetic Background of Japanese Patients with Nonalcoholic Steatohepatitis (NASH) -- Predictors of Nonalcoholic Steatohepatitis in Japanese Patients: Thioredoxin and NASH -- Clinical Features of Patients with Nonalcoholic Fatty Liver Disease -- Pathogenesis and Significance of Restricted Diet and Exercise Therapy in Nonalcoholic Steatohepatitis (NASH) -- Mammalian Target of Rapamycin (mTOR) -- Effect of Oral Supplementation with Branched-Chain Amino Acids on Albumin Concentration in the Early Stage of Cirrhosis -- Nutritional Therapy in Patients with Liver Cirrhosis.
|
650 |
|
0 |
|a Medicine.
|
650 |
|
0 |
|a Gastroenterology.
|
650 |
|
0 |
|a Hepatology.
|
650 |
1 |
4 |
|a Medicine & Public Health.
|
650 |
2 |
4 |
|a Hepatology.
|
650 |
2 |
4 |
|a Gastroenterology.
|
700 |
1 |
|
|a Okita, Kiwamu.
|e editor.
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer eBooks
|
776 |
0 |
8 |
|i Printed edition:
|z 9784431213888
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1007/b138712
|z Full Text via HEAL-Link
|
912 |
|
|
|a ZDB-2-SME
|
950 |
|
|
|a Medicine (Springer-11650)
|